Cell and Tissue Preservation Market Size (By Type: Cells and Tissues; By Application: Research and Development, Therapeutics, Drug Discovery, and Others; By Product: Biopreservation Media, Equipment, and Software; and By End user: Hospitals, Biobanks, and Others) - Global Industry Analysis, Market Size, Opportunities, and Forecast 2021 - 2028

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 250

The global cell and tissue preservation market is anticipated to grow at a CAGR of around 11.5% during the forecast period 2021-2028. The market was valued at around US$ 2.9 Billion in 2020.

Report coverage

Market Cell and Tissue Preservation Market
Analysis Period 2017 - 2028
Base Year 2020
Forecast Data 2021 - 2028
Segments Covered By Type, By Application, By Product, By End User and By Region
Regional Scope North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled Lonza, Merck KGaA,  Agilent Technologies, Inc., FUJIFILM Irvine Scientific, AMSBIO, STEMCELL Technologies Inc., Corning Incorporated, Thermo Fisher Scientific, Inc., BD, Cytiva, Avantor, Inc., BioLifeSolutions Inc., Princeton CryoTech, LGC SeraCare, CellGenix GmbH, among others
Report Coverage Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
Customization Scope 10 hrs of free customization and expert consultation

 

Market Dynamics

Deep freezing, freeze-drying, and cryopreservation are current methods involved in cell and tissue preservation. These methods are used mainly for the storage of meniscal allografts and ligaments. 

The major factor driving the cell and tissue preservation market is the increasing healthcare expenditure in different regions. Increasing investments in the healthcare sector anticipate access to quality healthcare and the development of life-saving products. Biopreservation is one of the major facilities where major key players are making investments thus aiding the growth of the cell and tissue preservation market. End-users of the market such as hospitals, gene banks, and biobanks are encouraging the industry players to make investments in the research and developments of advanced products to benefit patient outcomes. Another factor that supports the growth of the global market is the government initiatives in the form of funds and grants to encourage R&D activities by various universities and organizations. All these factors will fuel the adoption of biopreservation solutions and services thus boosting the growth of the global market during the forecast period.

Other major factors that will influence the global market during the forecast period are rising demand for regenerative medicines, growing cases of various types of cancers, neurological and cardiovascular disorders, diabetes, etc., and the growing demand for organ storage for transplants. Regenerative medicines are latest development in the healthcare sector, which are capable of engineering, replacing, and regenerating cells that are functional. They are used for the treatment of several disorders, diseases, or congenital defects. In recent years, there has been a significant rise in the storage of the organs mainly for transplants owing to the increasing patient population and for research purposes.

Segment Analysis by Region

Major regional diversification for the cell and tissue preservation market includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America anticipates being the dominant region in the cell and tissue preservation market with an attractiveness index of 2.0 during the forecast time frame. It also promises to showcase a high CAGR during the forecast period 2021-2028. The key factors influencing this growth are the increased healthcare investments and the developments in research activities in the biomedical field.

Other prominent regions contributing majorly to the growth of the cell and tissue preservation market are Asia Pacific and Europe. Increasing engagement of the pharmaceutical companies in the capitalization of the preservation equipment and its adoption has fueled the growth of the market. Growing patient population and the rise in the need for treatment of chronic diseases has significantly increased the demand for biopreservation solutions and services.

Competitive Landscape

The global cell and tissue preservation market is highly competitive due to the presence of increasing number of industry players and the innovations in the product offerings. In addition, the advancements and expansion in the biomedical field through research and development activities are the other factors increasing the competition in the market.

Cell and Tissue Preservation Market Segment Analysis 2020

The global cell and tissue preservation market is segmented into type, application, product, and end-user. In terms of type, the market is bifurcated into cells and tissue. By application, the global market is further categorized into research and development, therapeutics, drug discovery, and others. In terms of product, the market is segregated into biopreservation media, equipment, and software. By end-user, the market is segmented into hospitals, biobanks, and others. 

Tissues type segment anticipates holding the major share in the cell and tissue preservation market. The anticipated CAGR for the segment is above 11% during the forecast period 2021 to 2028. Growing investments in the research and development activities in order to collect, process, and store tissue samples for breakthrough studies and treatments is the major factor driving the growth of the segment.

In terms of end-user, biobanks show a promising growth rate during the forecast period. Different biospecimens are stored in the biobanks. These specimens include cells and tissues, organs or limbs, etc. The storage of the organs or cells helps in transplants and to cure various disorders and diseases. Thus, these factors aid the growth of the biobanks segment in the cell and tissue preservation market. 

The key industry players in the cell and tissue preservation market include Lonza, Merck KGaA,  Agilent Technologies, Inc., FUJIFILM Irvine Scientific, AMSBIO, STEMCELL Technologies Inc., Corning Incorporated, Thermo Fisher Scientific, Inc., BD, Cytiva, Avantor, Inc., BioLifeSolutions Inc., Princeton CryoTech, LGC SeraCare, CellGenix GmbH, among others. 

Market Segmentation

Market by Type

  • Cells
    • Mammalian Cells
    • Others (Microorganisms and Plant Cells)
  • Tissues
    • Blood
    • Bone
    • Soft Tissues
    • Skin
    • Others

Market by Application

  • Therapeutics
  • Research & Development
  • Drug Discovery
  • Others (Cosmetics and Clinical trials)

Market by Product

  • Equipment
    • Freezers
    • Thawing Equipment
    • Refrigerators
    • Storage Systems
    • Others
  • Bio Preservation Media
    • Home-brew Media
    • Pre-formulated Media
  • Software

Market by End User

  • Biobanks
  • Hospitals
  • Others

Market By Region

  • North America
    • US 
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil 
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa

Frequently Asked Questions

Cell and Tissue Preservation Market to reach around US$ 8.5 by 2028

North America anticipates being the dominant region in the cell and tissue preservation market with an attractiveness index of 2.0 during the forecast time frame.

Cart Summary